PURPOSE OF THE STUDY

To evaluate the results of the use of preventive stenting of the main pancreatic duct in patients after endoscopic transpapillary interventions in the prevention of acute postmanipulatory pancreatitis

MATERIAL AND METHODS

In the period from 2015—2021, 1135 endoscopic transpapillary interventions were performed. For benign pathology (papillostenosis, choledocholithiasis, adenomas of the major duodenal papilla strictures of the choledochus), 879 (77.4%) interventions and 256 (22.6%) manipulations were performed for malignant diseases of the pancreatoduodenal zone (cancer of the head of the pancreas, the large duodenal papilla of the major duodenal papilla gallbladder, metastases to the lymph nodes of the liver gate).

RESULTS

Risk factors for acute postmanipulatory pancreatitis are female, young age, difficulties in cannulation of the major duodenal papilla, atypical papillosphincterotomy. It is proved that in a group of patients who underwent preventive stenting of the main pancreatic duct, the risk of developing acute postmanipulatory pancreatitis decreases from 15.9 to 4.3%.

CONCLUSION

Preventive stenting of the main pancreatic duct, as the final stage of transpapillary endoscopic intervention, allows achieving a high preventive effect in relation to the occurrence of acute postmanipulatory pancreatitis.